HomeRSLS • NASDAQ
add
ReShape Lifesciences Inc
Previous close
$0.57
Day range
$0.45 - $0.55
Year range
$0.30 - $29.00
Market cap
5.21M USD
Avg Volume
23.97M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.80M | -8.93% |
Operating expense | 1.96M | -47.52% |
Net income | -1.76M | -3.71% |
Net profit margin | -97.56 | -13.88% |
Earnings per share | — | — |
EBITDA | -637.00K | 66.26% |
Effective tax rate | -0.28% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 693.00K | -84.46% |
Total assets | 4.79M | -55.05% |
Total liabilities | 5.05M | 26.15% |
Total equity | -253.00K | — |
Shares outstanding | 11.28M | — |
Price to book | -1.62 | — |
Return on assets | -30.84% | — |
Return on capital | -134.20% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.76M | -3.71% |
Cash from operations | -687.00K | 72.04% |
Cash from investing | — | — |
Cash from financing | 653.00K | -88.04% |
Net change in cash | -50.00K | -101.66% |
Free cash flow | 466.75K | 128.33% |
About
Founded
2002
Website
Employees
18
